Ghirelli, Alma
Spinelli, Edoardo Gioele
Canu, Elisa
Domi, Teuta
Basaia, Silvia
Castelnovo, Veronica
Pozzi, Laura
Magnani, Giuseppe
Caso, Francesca
Caroppo, Paola
Prioni, Sara
Villa, Cristina
Riva, Nilo
Quattrini, Angelo
Carrera, Paola
Filippi, Massimo
Agosta, Federica http://orcid.org/0000-0003-3121-4979
Funding for this research was provided by:
H2020 European Research Council (StG-2016_714388_NeuroTRACK)
Ministero dell’Istruzione, dell’Università e della Ricerca
Article History
Received: 5 June 2023
Revised: 19 June 2023
Accepted: 20 June 2023
First Online: 29 June 2023
Declarations
:
: A. Ghirelli, E.G. Spinelli, T. Domi, V. Castelnovo, L. Pozzi, G. Magnani, F. Caso, P. Caroppo, S. Prioni, C. Villa, N. Riva, A. Quattrini, and P. Carrera report no actual or potential conflicts of interest. E. Canu and S. Basaia have received research support from the Italian Ministry of Health. M. Filippi is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, <i>Neurological Sciences,</i> and <i>Radiology</i>; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Italian Ministry of Health, and Fondazione Italiana Sclerosi Multipla. F. Agosta is Section Editor of <i>NeuroImage: Clinical</i>; has received speaker honoraria from Biogen Idec, Roche, Zambon, Italfarmaco, and Eli Lilly; and receives or has received research supports from the Italian Ministry of Health, Italian Ministry of University and Research, AriSLA (Fondazione Italiana di Ricerca per la SLA), the European Research Council and the Foundation Research on Alzheimer Disease.
: The local ethical standards committee on human experimentation approved the study protocol and the patient provided written informed consent prior to being included in the present study.